ctrl K

Watchlist Price Alert

Psyence Biomedical Ltd. (PBM)

NASDAQ: PBM · Real-Time Price · USD

4.80

-0.42 (-8.05%)

At close: Jun 11, 2025, 3:59 PM

5.17

7.71%

Pre-market: Jun 12, 2025, 08:00 AM EDT

Psyence Biomedical Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue	n/a	n/a	n/a
Cost of Revenue	240.00	n/a	n/a
Gross Profit	-240	n/a	n/a
Operating Income	-2.75M	-1.29M	-334.29K
Interest Income	2.13K	1.55K	n/a
Pretax Income	-51.16M	8.01M	8.23M
Net Income	-51.16M	8.01M	8.23M
Selling & General & Admin	1.8M	1.29M	334.29K
Research & Development	954.59K	1.61M	137.24K
Other Expenses	879.34K	n/a	n/a
Operating Expenses	2.75M	1.29M	334.29K
Interest Expense	52.94K	n/a	n/a
Selling & Marketing Expenses	80.6K	7.03K	17.51K
Cost & Expenses	2.75M	1.29M	334.29K
Income Tax Expense	n/a	n/a	n/a
Shares Outstanding (Basic)	6.52M	32.67M	32.67M
Shares Outstanding (Diluted)	6.52M	32.67M	32.67M
EPS (Basic)	-7.85	-0.64	0.25
EPS (Diluted)	-7.85	-0.64	0.25
EBITDA	-2.75M	-1.29M	-334.29K
EBIT	-51.11M	n/a	n/a
Depreciation & Amortization	240.00	n/a	n/a